Detection of Chlamydia trachomatis and Neisseria gonorrhoeae based on cross-priming amplification

被引:9
|
作者
Yu, B. [1 ]
An, Y. [2 ]
Xu, G. [3 ]
Shan, H. [4 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China
[2] Yulin City First Hosp, Dept Gastroenterol, Xian, Shaanxi, Peoples R China
[3] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland
[4] Adicon Clin Labs, 398 Tianmushan Rd, Hangzhou, Zhejiang, Peoples R China
关键词
cross-priming amplification; cross-contamination proof device; disposable amplicon detection; polymerase chain reaction; resource-limited area; sexually transmitted disease; RESOURCE-LIMITED SETTINGS; INFECTIONS; TESTS; PCR;
D O I
10.1111/lam.12560
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rapid, sensitive and specific isothermal nucleic acid amplification methods of Chlamydia trachomatis (C.trachomatis) and Neisseria gonorrhoeae (N.gonorrhoeae) have been developed based on cross-priming amplification (CPA). The amplicon of CPA can be detected by a disposable amplicon cross-contamination proof device. The whole assay takes 1-15h from amplification to read out. Ten fold serial dilutions of quantified plasmids were used to test the CPA assay sensitivities, with the detection limits of 45 copies per reaction and 65 copies per reaction for C.trachomatis and N.gonorrhoeae respectively. The specificities of CPA assays for C.trachomatis and N.gonorrhoeae were tested by using total DNA extracted from nine other bacterial strains, and no cross-reactivity was detected. Eighty clinical cervical or vaginal swab specimens were tested by both CPA and real-time polymerase chain reaction (PCR) with the consistencies of 9875% (79/80) and 975% (78/80) for C.trachomatis and N.gonorrhoeae respectively. Using real-time PCR as a reference standard, the clinical sensitivity (positive) and specificity (negative) of CPA was found to be 9815% (53/54) and 100% (26/26) for C.trachomatis, and 9375% (30/32) and 100% (48/48) for N.gonorrhoeae. Eight swab specimens tested positive for both C.trachomatis and N.gonorrhoeae simultaneously by real-time PCR and CPA assay. This study demonstrated that CPA is an affordable and accessible assay for C.trachomatis and N.gonorrhoeae detection, with high sensitivity and specificity. Significance and Impact of the StudyRapid and specific detection of the sexually transmitted pathogens Chlamydia trachomatis (C.trachomatis) and Neisseria gonorrhoeae (N.gonorrhoeae) would enable early treatment and management of their spread. Here, for the first time, a user friendly DNA isothermal amplification method named cross-priming amplification (CPA), was used to test C.trachomatis and N.gonorrhoeae with high sensitivity and specificity. The results indicate that CPA has great potential for improving C.trachomatis and N.gonorrhoeae diagnostics which could be particularly advantageous in resource-limited areas.
引用
收藏
页码:399 / 403
页数:5
相关论文
共 50 条
  • [21] Nucleic Acid Amplification Tests for Diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis Rectal Infections
    Bachmann, Laura H.
    Johnson, Robert E.
    Cheng, Hong
    Markowitz, Lauri
    Papp, John R.
    Palella, Frank J., Jr.
    Hook, Edward W., III
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (05) : 1827 - 1832
  • [22] Comparative Evaluation of 2 Nucleic Acid Amplification Tests for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae at Extragenital Sites
    Bristow, Claire C.
    McGrath, Mark R.
    Cohen, Adam C.
    Anderson, Laura J.
    Gordon, Kristie K.
    Klausner, Jeffrey D.
    SEXUALLY TRANSMITTED DISEASES, 2017, 44 (07) : 398 - 400
  • [23] Molecular--based Testing for the Detection of Rectal and Oropharyngeal* Chlamydia trachomatis and Neisseria gonorrhoeae Infections
    Dixon, Paula B.
    Cammarata, Catherine L.
    Ippolito, Jordan
    Lockamy, Elizabeth
    Taylor, Stephanie
    Van der Pol, Barbara
    SEXUALLY TRANSMITTED DISEASES, 2024, 51 (01) : S211 - S212
  • [24] DNA stability of Chlamydia trachomatis and Neisseria gonorrhoeae in urine
    Le Guern, Remi
    Miaux, Brigitte
    Pischedda, Patricia
    Herwegh, Stephanie
    Courcol, Rene
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 85 (03) : 313 - 314
  • [25] Evaluation of 2-SP transport medium for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by two automated amplification systems and culture for chlamydia
    Dubuis, O
    GorgievskiHrisoho, M
    Germann, D
    Matter, L
    JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (11) : 947 - 950
  • [26] CLINICAL EVALUATION OF THE PELVOCHECK® CT/NG FOR THE DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE
    Kilic, A.
    Kofler, R.
    Haenel, K.
    Meyer, T.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A92 - A93
  • [27] Chlamydia trachomatis and Neisseria gonorrhoeae PCR detection in women treated for ectopic pregnancy
    Rackova, Jana
    Zahumensky, Jozef
    Zikan, Michael
    Menzlova, Erika
    Sehnal, Borek
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (05) : 1370 - 1373
  • [28] Cobas® 4800: a fully automated system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae
    Van der Pol, Barbara
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (02) : 131 - 140
  • [29] TREATMENT OF NEISSERIA-GONORRHOEAE AND CHLAMYDIA-TRACHOMATIS
    JACOBS, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (02): : 125 - 125
  • [30] Swingers, an emerging riskgroup for Chlamydia trachomatis and Neisseria gonorrhoeae
    Hoebe, C. J. P. A.
    Brouwers, E. E. G. H.
    Morre, S. A.
    Bruggeman, C. A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2007, 17 : 188 - 188